Q2 2026 Holdings
Filed 2026-08-14 | 25 holdings | $113.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Definium Therapeutics Inc(DFTX)Call | COM SHS | 24477V105 | $18.8M | 400,000 | 16.6% |
| Abivax SA(ABVX)Call | SPONSORED ADS | 00370M103 | $16.7M | 125,000 | 14.7% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $12.1M | 2,175,802 | 10.7% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $8.2M | 620,319 | 7.2% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $5.7M | 284,287 | 5.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $4.0M | 16,493 | 3.6% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $3.8M | 140,000 | 3.4% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $3.7M | 817,939 | 3.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.4M | 83,300 | 3.0% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $3.2M | 249,172 | 2.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.2M | 290,000 | 2.8% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $2.9M | 775,000 | 2.6% |
| Avalo Therapeutics Inc(AVTX) | SPONSORED ADS | 05338F306 | $2.8M | 150,000 | 2.5% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $2.6M | 1,229,000 | 2.3% |
| Solid Biosciences Inc(SLDB) | COM | 83422E204 | $2.6M | 255,959 | 2.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.5M | 526,315 | 2.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.5M | 69,183 | 2.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $2.5M | 743,958 | 2.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.5M | 67,500 | 2.2% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.4M | 634,800 | 2.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $2.2M | 76,459 | 1.9% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.7M | 624,561 | 1.5% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $1.7M | 252,175 | 1.5% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $682.8K | 390,147 | 0.6% |
| Traws Pharma Inc(TRAW) | COM | 68232V884 | $663.0K | 786,236 | 0.6% |